Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer

Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer

Objective: The oncoprotein, hepatitis B X-interacting protein (HBXIP), has been reported to play an important role in human malignancies. However, its functions in non-small cell lung cancer (NSCLC) are poorly understood. The goal of the present study was to identify the role of HBXIP in the regulat...

Full description

Bibliographic Details
Main Authors: Jun Zhang, Bei Sun, Xianhui Ruan, Xiukun Hou, Jingtai Zhi, Xiangrui Meng, Xiangqian Zheng, Ming Gao
Format: Article
Language:English
Published: China Anti-Cancer Association 2021-02-01
Series:Cancer Biology & Medicine
Subjects:
hbxip
non-small cell lung cancer
mek1
tumor progression
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1774

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/1774

Similar Items